Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 328

1.

A computational model of induced pluripotent stem-cell derived cardiomyocytes incorporating experimental variability from multiple data sources.

Kernik DC, Morotti S, Wu H, Garg P, Duff HJ, Kurokawa J, Jalife J, Wu JC, Grandi E, Clancy CE.

J Physiol. 2019 Jul 6. doi: 10.1113/JP277724. [Epub ahead of print]

PMID:
31278749
2.

Functional cardiac fibroblasts derived from human pluripotent stem cells via second heart field progenitors.

Zhang J, Tao R, Campbell KF, Carvalho JL, Ruiz EC, Kim GC, Schmuck EG, Raval AN, da Rocha AM, Herron TJ, Jalife J, Thomson JA, Kamp TJ.

Nat Commun. 2019 May 20;10(1):2238. doi: 10.1038/s41467-019-09831-5.

3.

Lesion Index Titration Using Contact-Force Technology Enables Safe and Effective Radiofrequency Lesion Creation at the Root of the Aorta and Pulmonary Artery.

Alfonso-Almazán JM, Quintanilla JG, García-Torrent MJ, Laguna-Castro S, Rodríguez-Bobada C, González P, González-Ferrer JJ, Salinas P, Cañadas-Godoy V, Moreno J, Borrego-Bernabé L, Pérez-Castellano N, Jalife J, Perez-Villacastín J, Filgueiras-Rama D.

Circ Arrhythm Electrophysiol. 2019 Mar;12(3):e007080. doi: 10.1161/CIRCEP.118.007080.

4.

Clinical Characteristics and Electrophysiological Mechanisms Underlying Brugada ECG in Patients With Severe Hyperkalemia.

Rivera-Juárez A, Hernández-Romero I, Puertas C, Zhang-Wang S, Sánchez-Álamo B, Martins R, Figuera C, Guillem MS, Climent AM, Fernández-Avilés F, Tejedor A, Jalife J, Atienza F.

J Am Heart Assoc. 2019 Feb 5;8(3):e010115. doi: 10.1161/JAHA.118.010115.

5.

Three-dimensional cardiac fibre disorganization as a novel parameter for ventricular arrhythmia stratification after myocardial infarction.

León DG, López-Yunta M, Alfonso-Almazán JM, Marina-Breysse M, Quintanilla JG, Sánchez-González J, Galán-Arriola C, Castro-Núñez F, González-Ferrer JJ, Ibáñez B, Pérez-Villacastín J, Pérez-Castellano N, Fuster V, Jalife J, Vázquez M, Aguado-Sierra J, Filgueiras-Rama D.

Europace. 2019 Jan 12. doi: 10.1093/europace/euy306. [Epub ahead of print]

6.

Implications of bipolar voltage mapping and magnetic resonance imaging resolution in biventricular scar characterization after myocardial infarction.

López-Yunta M, León DG, Alfonso-Almazán JM, Marina-Breysse M, Quintanilla JG, Sánchez-González J, Galán-Arriola C, Cañadas-Godoy V, Enríquez-Vázquez D, Torres C, Ibáñez B, Pérez-Villacastín J, Pérez-Castellano N, Jalife J, Vázquez M, Aguado-Sierra J, Filgueiras-Rama D.

Europace. 2019 Jan 1;21(1):163-174. doi: 10.1093/europace/euy192.

PMID:
30239689
7.

Brugada syndrome trafficking-defective Nav1.5 channels can trap cardiac Kir2.1/2.2 channels.

Pérez-Hernández M, Matamoros M, Alfayate S, Nieto-Marín P, Utrilla RG, Tinaquero D, de Andrés R, Crespo T, Ponce-Balbuena D, Willis BC, Jiménez-Vazquez EN, Guerrero-Serna G, da Rocha AM, Campbell K, Herron TJ, Díez-Guerra FJ, Tamargo J, Jalife J, Caballero R, Delpón E.

JCI Insight. 2018 Sep 20;3(18). pii: 96291. doi: 10.1172/jci.insight.96291. eCollection 2018 Sep 20.

8.

Biobank-driven genomic discovery yields new insight into atrial fibrillation biology.

Nielsen JB, Thorolfsdottir RB, Fritsche LG, Zhou W, Skov MW, Graham SE, Herron TJ, McCarthy S, Schmidt EM, Sveinbjornsson G, Surakka I, Mathis MR, Yamazaki M, Crawford RD, Gabrielsen ME, Skogholt AH, Holmen OL, Lin M, Wolford BN, Dey R, Dalen H, Sulem P, Chung JH, Backman JD, Arnar DO, Thorsteinsdottir U, Baras A, O'Dushlaine C, Holst AG, Wen X, Hornsby W, Dewey FE, Boehnke M, Kheterpal S, Mukherjee B, Lee S, Kang HM, Holm H, Kitzman J, Shavit JA, Jalife J, Brummett CM, Teslovich TM, Carey DJ, Gudbjartsson DF, Stefansson K, Abecasis GR, Hveem K, Willer CJ.

Nat Genet. 2018 Sep;50(9):1234-1239. doi: 10.1038/s41588-018-0171-3. Epub 2018 Jul 30.

9.

Mechanisms and Drug Development in Atrial Fibrillation.

Calvo D, Filgueiras-Rama D, Jalife J.

Pharmacol Rev. 2018 Jul;70(3):505-525. doi: 10.1124/pr.117.014183. Review.

10.

The tornadoes of sudden cardiac arrest.

Jalife J.

Nature. 2018 Mar 29;555(7698):597-598. doi: 10.1038/d41586-018-01950-1. No abstract available.

PMID:
29595799
11.

Cardiac Kir2.1 and NaV1.5 Channels Traffic Together to the Sarcolemma to Control Excitability.

Ponce-Balbuena D, Guerrero-Serna G, Valdivia CR, Caballero R, Diez-Guerra FJ, Jiménez-Vázquez EN, Ramírez RJ, Monteiro da Rocha A, Herron TJ, Campbell KF, Willis BC, Alvarado FJ, Zarzoso M, Kaur K, Pérez-Hernández M, Matamoros M, Valdivia HH, Delpón E, Jalife J.

Circ Res. 2018 May 25;122(11):1501-1516. doi: 10.1161/CIRCRESAHA.117.311872. Epub 2018 Mar 7.

12.

Factors affecting basket catheter detection of real and phantom rotors in the atria: A computational study.

Martinez-Mateu L, Romero L, Ferrer-Albero A, Sebastian R, Rodríguez Matas JF, Jalife J, Berenfeld O, Saiz J.

PLoS Comput Biol. 2018 Mar 5;14(3):e1006017. doi: 10.1371/journal.pcbi.1006017. eCollection 2018 Mar.

13.

Causality analysis of leading singular value decomposition modes identifies rotor as the dominant driving normal mode in fibrillation.

Biton Y, Rabinovitch A, Braunstein D, Aviram I, Campbell K, Mironov S, Herron T, Jalife J, Berenfeld O.

Chaos. 2018 Jan;28(1):013128. doi: 10.1063/1.5021261.

14.

Genome-wide Study of Atrial Fibrillation Identifies Seven Risk Loci and Highlights Biological Pathways and Regulatory Elements Involved in Cardiac Development.

Nielsen JB, Fritsche LG, Zhou W, Teslovich TM, Holmen OL, Gustafsson S, Gabrielsen ME, Schmidt EM, Beaumont R, Wolford BN, Lin M, Brummett CM, Preuss MH, Refsgaard L, Bottinger EP, Graham SE, Surakka I, Chu Y, Skogholt AH, Dalen H, Boyle AP, Oral H, Herron TJ, Kitzman J, Jalife J, Svendsen JH, Olesen MS, Njølstad I, Løchen ML, Baras A, Gottesman O, Marcketta A, O'Dushlaine C, Ritchie MD, Wilsgaard T, Loos RJF, Frayling TM, Boehnke M, Ingelsson E, Carey DJ, Dewey FE, Kang HM, Abecasis GR, Hveem K, Willer CJ.

Am J Hum Genet. 2018 Jan 4;102(1):103-115. doi: 10.1016/j.ajhg.2017.12.003. Epub 2017 Dec 28.

15.

Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling.

Takemoto Y, Ramirez RJ, Kaur K, Salvador-Montañés O, Ponce-Balbuena D, Ramos-Mondragón R, Ennis SR, Guerrero-Serna G, Berenfeld O, Jalife J.

J Am Coll Cardiol. 2017 Dec 12;70(23):2893-2905. doi: 10.1016/j.jacc.2017.10.014.

16.

Structural basis for the antiarrhythmic blockade of a potassium channel with a small molecule.

Takemoto Y, Slough DP, Meinke G, Katnik C, Graziano ZA, Chidipi B, Reiser M, Alhadidy MM, Ramirez R, Salvador-Montañés O, Ennis S, Guerrero-Serna G, Haburcak M, Diehl C, Cuevas J, Jalife J, Bohm A, Lin YS, Noujaim SF.

FASEB J. 2018 Apr;32(4):1778-1793. doi: 10.1096/fj.201700349R. Epub 2018 Jan 5.

17.

Synergistic Research Between the Center of Arrhythmia Research and the Michigan Biology of Cardiovascular Aging at the University of Michigan.

Goldstein DR, Jalife J.

Circ Res. 2017 Nov 10;121(11):1221-1223. doi: 10.1161/CIRCRESAHA.117.311374. No abstract available.

18.

Triple threat: adiposity, aging, atrial fibrillation.

Anumonwo JM, Jalife J, Goldstein DR.

Aging (Albany NY). 2017 Nov 1;9(11):2235-2236. doi: 10.18632/aging.101318. No abstract available.

19.

hiPSC-CM Monolayer Maturation State Determines Drug Responsiveness in High Throughput Pro-Arrhythmia Screen.

da Rocha AM, Campbell K, Mironov S, Jiang J, Mundada L, Guerrero-Serna G, Jalife J, Herron TJ.

Sci Rep. 2017 Oct 23;7(1):13834. doi: 10.1038/s41598-017-13590-y.

20.

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.

Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, d'Avila A, de Groot NMSN, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T.

J Arrhythm. 2017 Oct;33(5):369-409. doi: 10.1016/j.joa.2017.08.001. Epub 2017 Sep 15. No abstract available.

21.

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.

Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, d'Avila A, de Groot NMSN, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T.

Europace. 2018 Jan 1;20(1):157-208. doi: 10.1093/europace/eux275. Review. No abstract available.

22.

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Cosedis Nielsen J, Curtis AB, Davies DW, Day JD, d'Avila A, Natasja de Groot NMS, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T; Document Reviewers:.

Europace. 2018 Jan 1;20(1):e1-e160. doi: 10.1093/europace/eux274. Review. No abstract available.

23.

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary.

Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Wyn Davies D, Day JD, d'Avila A, de Groot NMSN, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T.

J Interv Card Electrophysiol. 2017 Oct;50(1):1-55. doi: 10.1007/s10840-017-0277-z. No abstract available.

24.

Propagation of Sinus Waves in the Atrial Architecture: When Laminar Electrical Fluxes Turn Turbulent.

Calvo D, Filgueiras-Rama D, Jalife J.

Circ Arrhythm Electrophysiol. 2017 Sep;10(9). pii: e005699. doi: 10.1161/CIRCEP.117.005699. No abstract available.

25.

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, d'Avila A, de Groot NMSN, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T.

Heart Rhythm. 2017 Oct;14(10):e275-e444. doi: 10.1016/j.hrthm.2017.05.012. Epub 2017 May 12. No abstract available.

26.

Is TGF-β1 (Transforming Growth Factor-β1) an Enabler of Myofibroblast-Cardiomyocyte Cross Talk?

Kaur K, Jalife J.

Circ Arrhythm Electrophysiol. 2017 May;10(5):e005289. doi: 10.1161/CIRCEP.117.005289. No abstract available.

27.

Selection of the Best of 2016 in Catheter Ablation.

Filgueiras-Rama D, Bogun F, Pérez-Castellano N, Morady F, Jalife J, Pérez-Villacastín J.

Rev Esp Cardiol (Engl Ed). 2017 Apr;70(4):302-303. doi: 10.1016/j.rec.2016.12.021. English, Spanish. No abstract available.

28.

Tbx20 controls the expression of the KCNH2 gene and of hERG channels.

Caballero R, Utrilla RG, Amorós I, Matamoros M, Pérez-Hernández M, Tinaquero D, Alfayate S, Nieto-Marín P, Guerrero-Serna G, Liu QH, Ramos-Mondragón R, Ponce-Balbuena D, Herron T, Campbell KF, Filgueiras-Rama D, Peinado R, López-Sendón JL, Jalife J, Delpón E, Tamargo J.

Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):E416-E425. doi: 10.1073/pnas.1612383114. Epub 2017 Jan 3.

29.

Scn2b Deletion in Mice Results in Ventricular and Atrial Arrhythmias.

Bao Y, Willis BC, Frasier CR, Lopez-Santiago LF, Lin X, Ramos-Mondragón R, Auerbach DS, Chen C, Wang Z, Anumonwo J, Valdivia HH, Delmar M, Jalife J, Isom LL.

Circ Arrhythm Electrophysiol. 2016 Dec;9(12). pii: e003923.

30.

Cardiac electrical defects in progeroid mice and Hutchinson-Gilford progeria syndrome patients with nuclear lamina alterations.

Rivera-Torres J, Calvo CJ, Llach A, Guzmán-Martínez G, Caballero R, González-Gómez C, Jiménez-Borreguero LJ, Guadix JA, Osorio FG, López-Otín C, Herraiz-Martínez A, Cabello N, Vallmitjana A, Benítez R, Gordon LB, Jalife J, Pérez-Pomares JM, Tamargo J, Delpón E, Hove-Madsen L, Filgueiras-Rama D, Andrés V.

Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):E7250-E7259. Epub 2016 Oct 31.

31.

Reply: The Role of Pro-Fibrotic Biomarkers in Atrial Fibrillation: How Good Are We in the Translational Interpretation?

Takemoto Y, Kaur K, Oral H, Jalife J.

JACC Basic Transl Sci. 2016 Oct 31;1(6):552-553. doi: 10.1016/j.jacbts.2016.09.002. eCollection 2016 Oct. No abstract available.

32.

Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes.

Monteiro da Rocha A, Guerrero-Serna G, Helms A, Luzod C, Mironov S, Russell M, Jalife J, Day SM, Smith GD, Herron TJ.

J Mol Cell Cardiol. 2016 Oct;99:197-206. doi: 10.1016/j.yjmcc.2016.09.004. Epub 2016 Sep 10.

33.

EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.

Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, Chugh SS, Corradi D, D'Avila A, Dobrev D, Fenelon G, Gonzalez M, Hatem SN, Helm R, Hindricks G, Ho SY, Hoit B, Jalife J, Kim YH, Lip GY, Ma CS, Marcus GM, Murray K, Nogami A, Sanders P, Uribe W, Van Wagoner DR, Nattel S; Document Reviewers: Osmar A. Centurion (Paraguay), Karl-Heinz Kuck (Germany), Kristen K. Patton (USA), John L. Sapp (Canada), Martin Stiles (New Zealand), Jesper Hastrup Svendsen (Denmark), and Gaurav A. Upadhyay (USA); Review coordinator: Alena Shantsila (UK).

J Arrhythm. 2016 Aug;32(4):247-78. doi: 10.1016/j.joa.2016.05.002. Epub 2016 Jul 11. No abstract available.

34.

miR-208b upregulation interferes with calcium handling in HL-1 atrial myocytes: Implications in human chronic atrial fibrillation.

Cañón S, Caballero R, Herraiz-Martínez A, Pérez-Hernández M, López B, Atienza F, Jalife J, Hove-Madsen L, Delpón E, Bernad A.

J Mol Cell Cardiol. 2016 Oct;99:162-173. doi: 10.1016/j.yjmcc.2016.08.012. Epub 2016 Aug 18.

PMID:
27545043
35.

Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation Outcomes.

Takemoto Y, Ramirez RJ, Yokokawa M, Kaur K, Ponce-Balbuena D, Sinno MC, Willis BC, Ghanbari H, Ennis SR, Guerrero-Serna G, Henzi BC, Latchamsetty R, Ramos-Mondragon R, Musa H, Martins RP, Pandit SV, Noujaim SF, Crawford T, Jongnarangsin K, Pelosi F, Bogun F, Chugh A, Berenfeld O, Morady F, Oral H, Jalife J.

JACC Basic Transl Sci. 2016 Apr;1(3):143-154.

36.

Complement Destabilizes Cardiomyocyte Function In Vivo after Polymicrobial Sepsis and In Vitro.

Kalbitz M, Fattahi F, Herron TJ, Grailer JJ, Jajou L, Lu H, Huber-Lang M, Zetoune FS, Sarma JV, Day SM, Russell MW, Jalife J, Ward PA.

J Immunol. 2016 Sep 15;197(6):2353-61. doi: 10.4049/jimmunol.1600091. Epub 2016 Aug 12.

37.

Dynamics and Molecular Mechanisms of Ventricular Fibrillation in Structurally Normal Hearts.

Jalife J.

Card Electrophysiol Clin. 2016 Sep;8(3):601-12. doi: 10.1016/j.ccep.2016.04.009. Epub 2016 Jun 24. Review.

PMID:
27521093
38.

EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication.

Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, Chugh SS, Corradi D, D'Avila A, Dobrev D, Fenelon G, Gonzalez M, Hatem SN, Helm R, Hindricks G, Ho SY, Hoit B, Jalife J, Kim YH, Lip GY, Ma CS, Marcus GM, Murray K, Nogami A, Sanders P, Uribe W, Van Wagoner DR, Nattel S; Document Reviewers:.

Europace. 2016 Oct;18(10):1455-1490. Epub 2016 Jul 8. No abstract available.

39.

EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, Chugh SS, Corradi D, D'Avila A, Dobrev D, Fenelon G, Gonzalez M, Hatem SN, Helm R, Hindricks G, Ho SY, Hoit B, Jalife J, Kim YH, Lip GY, Ma CS, Marcus GM, Murray K, Nogami A, Sanders P, Uribe W, Van Wagoner DR, Nattel S.

Heart Rhythm. 2017 Jan;14(1):e3-e40. doi: 10.1016/j.hrthm.2016.05.028. Epub 2016 Jun 10. Review. No abstract available.

40.

Atrial Fibrillation Susceptibility in Obesity: An Excess Adiposity and Fibrosis Complicity?

Pandit SV, Anumonwo J, Jalife J.

Circ Res. 2016 May 13;118(10):1468-1471. doi: 10.1161/CIRCRESAHA.116.308686. Review. No abstract available.

41.

Constitutive Intracellular Na+ Excess in Purkinje Cells Promotes Arrhythmogenesis at Lower Levels of Stress Than Ventricular Myocytes From Mice With Catecholaminergic Polymorphic Ventricular Tachycardia.

Willis BC, Pandit SV, Ponce-Balbuena D, Zarzoso M, Guerrero-Serna G, Limbu B, Deo M, Camors E, Ramirez RJ, Mironov S, Herron TJ, Valdivia HH, Jalife J.

Circulation. 2016 Jun 14;133(24):2348-59. doi: 10.1161/CIRCULATIONAHA.116.021936. Epub 2016 May 11.

42.

Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production.

Hattangady NG, Karashima S, Yuan L, Ponce-Balbuena D, Jalife J, Gomez-Sanchez CE, Auchus RJ, Rainey WE, Else T.

J Mol Endocrinol. 2016 Jul;57(1):1-11. doi: 10.1530/JME-15-0324. Epub 2016 Apr 20.

43.

Extracellular Matrix-Mediated Maturation of Human Pluripotent Stem Cell-Derived Cardiac Monolayer Structure and Electrophysiological Function.

Herron TJ, Rocha AM, Campbell KF, Ponce-Balbuena D, Willis BC, Guerrero-Serna G, Liu Q, Klos M, Musa H, Zarzoso M, Bizy A, Furness J, Anumonwo J, Mironov S, Jalife J.

Circ Arrhythm Electrophysiol. 2016 Apr;9(4):e003638. doi: 10.1161/CIRCEP.113.003638.

44.
45.

Pulmonary vein triggers, focal sources, rotors and atrial cardiomyopathy: implications for the choice of the most effective ablation therapy.

Pison L, Tilz R, Jalife J, Haïssaguerre M.

J Intern Med. 2016 May;279(5):449-56. doi: 10.1111/joim.12490. Epub 2016 Mar 16. Review.

46.

Novel Upstream Approaches to Prevent Atrial Fibrillation Perpetuation.

Jalife J.

Heart Fail Clin. 2016 Apr;12(2):309-22. doi: 10.1016/j.hfc.2015.08.024. Review.

PMID:
26968673
47.

Mechanisms of Atrial Fibrillation: Rotors, Ionic Determinants, and Excitation Frequency.

Berenfeld O, Jalife J.

Heart Fail Clin. 2016 Apr;12(2):167-78. doi: 10.1016/j.hfc.2015.08.014. Review.

48.

Nav1.5 N-terminal domain binding to α1-syntrophin increases membrane density of human Kir2.1, Kir2.2 and Nav1.5 channels.

Matamoros M, Pérez-Hernández M, Guerrero-Serna G, Amorós I, Barana A, Núñez M, Ponce-Balbuena D, Sacristán S, Gómez R, Tamargo J, Caballero R, Jalife J, Delpón E.

Cardiovasc Res. 2016 May 15;110(2):279-90. doi: 10.1093/cvr/cvw009. Epub 2016 Jan 19.

49.

Mechanistic Approaches to Detect, Target, and Ablate the Drivers of Atrial Fibrillation.

Quintanilla JG, Pérez-Villacastín J, Pérez-Castellano N, Pandit SV, Berenfeld O, Jalife J, Filgueiras-Rama D.

Circ Arrhythm Electrophysiol. 2016 Jan;9(1):e002481. doi: 10.1161/CIRCEP.115.002481. Review. No abstract available.

50.

Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria.

Haemers P, Hamdi H, Guedj K, Suffee N, Farahmand P, Popovic N, Claus P, LePrince P, Nicoletti A, Jalife J, Wolke C, Lendeckel U, Jaïs P, Willems R, Hatem SN.

Eur Heart J. 2017 Jan 1;38(1):53-61. doi: 10.1093/eurheartj/ehv625. Epub 2015 Nov 26.

PMID:
26612579

Supplemental Content

Loading ...
Support Center